Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction

被引:0
|
作者
T Nagasaki
M Hara
H Nakanishi
H Takahashi
M Sato
H Takeyama
机构
[1] Nagoya City University,Department of Gastroenterological Surgery
[2] 1 Kawasumi,Division of Oncological Pathology
[3] Mizuho-cho,undefined
[4] Mizuho-ku,undefined
[5] Nagoya 467-8601,undefined
[6] Japan,undefined
[7] Aichi Cancer Center Institute,undefined
[8] 1-1 Kanokoden,undefined
[9] Chikusa-ku,undefined
[10] Nagoya 464-8681,undefined
[11] Japan,undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
cancer-associated fibroblast (CAF); cancer-stroma interaction (CSI); Interlerukin-6 (IL-6); angiogenesis; VEGF; colon cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:469 / 478
页数:9
相关论文
共 40 条
  • [1] Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction
    Nagasaki, T.
    Hara, M.
    Nakanishi, H.
    Takahashi, H.
    Sato, M.
    Takeyama, H.
    BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 469 - 478
  • [2] Interleukin-6 released by cancer-associated fibroblasts is critical for angiogenesis in oral squamous cell carcinoma
    Goda, Hiroyuki
    Okamoto, Masato
    Tokuzen, Norihiko
    Nakashiro, Koh-ichi
    CANCER SCIENCE, 2018, 109 : 513 - 513
  • [3] Anti-interleukin-6 receptor antibody suppressed oral squamous cell carcinoma by inhibiting tumor-stroma interaction
    Goda, H.
    Okamoto, M.
    Nakashiro, K. -I.
    Tokuzen, N.
    Hamakawa, H.
    ANNALS OF ONCOLOGY, 2015, 26 : 2 - 2
  • [4] Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
    Noriyuki Nishiwaki
    Kazuhiro Noma
    Toshiaki Ohara
    Tomoyoshi Kunitomo
    Kento Kawasaki
    Masaaki Akai
    Teruki Kobayashi
    Toru Narusaka
    Hajime Kashima
    Hiroaki Sato
    Satoshi Komoto
    Takuya Kato
    Naoaki Maeda
    Satoru Kikuchi
    Shunsuke Tanabe
    Hiroshi Tazawa
    Yasuhiro Shirakawa
    Toshiyoshi Fujiwara
    Cancer Immunology, Immunotherapy, 2023, 72 : 2029 - 2044
  • [5] Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
    Nishiwaki, Noriyuki
    Noma, Kazuhiro
    Ohara, Toshiaki
    Kunitomo, Tomoyoshi
    Kawasaki, Kento
    Akai, Masaaki
    Kobayashi, Teruki
    Narusaka, Toru
    Kashima, Hajime
    Sato, Hiroaki
    Komoto, Satoshi
    Kato, Takuya
    Maeda, Naoaki
    Kikuchi, Satoru
    Tanabe, Shunsuke
    Tazawa, Hiroshi
    Shirakawa, Yasuhiro
    Fujiwara, Toshiyoshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2029 - 2044
  • [6] Tc-99m-labeled anti-interleukin-6 receptor antibody for in vivo interleukin-6 receptor imaging.
    Sugimoto, K
    Nishimoto, N
    Danno, N
    Kishimoto, T
    Yoshizaki, K
    Arano, Y
    Ono, M
    Saji, H
    Nishimura, T
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 220P - 220P
  • [7] Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328
    Steiner, Hannes
    Cavarretta, Ilaria T.
    Moser, Patrizia L.
    Berger, Andreas P.
    Bektic, Jasmin
    Dietrich, Hermann
    Zaki, Mohamed H.
    Nakada, Marian
    Hobisch, Alfred
    Nemeth, Jeffrey A.
    Culig, Zoran
    PROSTATE, 2006, 66 (16): : 1744 - 1752
  • [8] Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells
    Hsu, Chih-Ping
    Chen, Yung-Liang
    Huang, Chiu-Chen
    Chou, Chih-Chung
    Liu, Chia-Ling
    Hung, Chih-Hung
    Kao, Ting-Yu
    Chung, Yuan-Chiang
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (03) : 277 - 284
  • [9] BLOCKING INTERLEUKIN-6 (IL-6) BY AN ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) MONOCLONAL ANTIBODY IN RHEUMATOID ARTHRITIS (RA)
    Choy, E. H. S.
    Isenberg, D. A.
    Garrood, T.
    Farrow, S.
    Ioannou, Y.
    Bird, H.
    Cheung, N.
    Williams, B. D.
    Hazleman, B.
    Price, R.
    Kishimoto, T.
    Panayi, G. S.
    RHEUMATOLOGY, 2002, 41 : 15 - 15
  • [10] Tumour-stroma interaction:: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
    Micke, P
    Östman, A
    LUNG CANCER, 2004, 45 : S163 - S175